ALLISON BREWER-REED: Open Payments
NPI 1427038983 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$899 in 44 payments from 17 companies in 2025. Trend: 2023 $1,847 · 2024 $2,125 · 2025 $899
Food & beverage: $899
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $192 |
| Novo Nordisk Inc | 7 | $134 |
| Lilly USA, LLC | 7 | $120 |
| Vanda Pharmaceuticals Inc. | 4 | $67 |
| Exact Sciences Corporation | 3 | $59 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $48 |
| PFIZER INC. | 2 | $45 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| Axsome Therapeutics, Inc. | 2 | $33 |
| Abbott Laboratories | 1 | $25 |
Products named: QULIPTA, MOUNJARO, Ozempic, VRAYLAR, JARDIANCE, ELIQUIS, The Cologuard Plus Collection Kit, REXULTI.
Industry payments across FL — which companies pay providers there.
